An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy

被引:310
作者
Steinlein, OK
Magnusson, A
Stoodt, J
Bertrand, S
Weiland, S
Berkovic, SF
Nakken, KO
Propping, P
Bertrand, D
机构
[1] UNIV OSLO, ULLEVAAL HOSP, DEPT PSYCHIAT, N-0407 OSLO, NORWAY
[2] NATL CTR EPILEPSY, SANDVIKA, NORWAY
[3] FAC MED, DEPT PHYSIOL, GENEVA, SWITZERLAND
[4] UNIV MELBOURNE, DEPT MED NEUROL, MELBOURNE, VIC, AUSTRALIA
关键词
D O I
10.1093/hmg/6.6.943
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is the first, and to date only, idiopathic epilepsy for which a specific mutation has been found, A missense mutation in the critical M2 domain of the alpha 4 subunit of the neuronal nicotinic acetylcholine receptor (CHRNA4) has been recently identified in one large Australian pedigree. Here we describe a novel mutation in the M2 domain of the CHRNA4 gene in a Norwegian family Three nucleotides (GCT) were inserted at nucleotide position 776 into the coding region for the C-terminal end of the M2 domain, Physiological investigations of the receptor reconstituted with the mutated CHRNA4 subunit reveal that this insertion does not prevent the receptor function but increases its apparent affinity for ACh. In addition, this mutant receptor shows a significantly lower calcium permeability that, at the cellular level, may correspond to a loss of function, Comparison of the two mutations identified so far in families with ADNFLE illustrates that different mutations can result in similar phenotypes.
引用
收藏
页码:943 / 947
页数:5
相关论文
共 27 条
  • [1] ELECTROPHYSIOLOGY OF A CHICK NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR EXPRESSED IN XENOPUS OOCYTES AFTER CDNA INJECTION
    BALLIVET, M
    NEF, P
    COUTURIER, S
    RUNGGER, D
    BADER, CR
    BERTRAND, D
    COOPER, E
    [J]. NEURON, 1988, 1 (09) : 847 - 852
  • [2] Beaudet AL, 1996, HUM MUTAT, V8, P197
  • [3] MUTATIONS AT 2 DISTINCT SITES WITHIN THE CHANNEL DOMAIN M2 ALTER CALCIUM PERMEABILITY OF NEURONAL ALPHA-7 NICOTINIC RECEPTOR
    BERTRAND, D
    GALZI, JL
    DEVILLERSTHIERY, A
    BERTRAND, S
    CHANGEUX, JP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) : 6971 - 6975
  • [4] UNCONVENTIONAL PHARMACOLOGY OF A NEURONAL NICOTINIC RECEPTOR MUTATED IN THE CHANNEL DOMAIN
    BERTRAND, D
    DEVILLERSTHIERY, A
    REVAH, F
    GALZI, JL
    HUSSY, N
    MULLE, C
    BERTRAND, S
    BALLIVET, M
    CHANGEUX, JP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (04) : 1261 - 1265
  • [5] ACTIVATION AND BLOCKING OF NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR RECONSTITUTED IN XENOPUS OOCYTES
    BERTRAND, D
    BALLIVET, M
    RUNGGER, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (05) : 1993 - 1997
  • [6] Bertrand D, 1991, METHODS NEUROSCIENCE, V4, P174
  • [7] Buisson B, 1996, J NEUROSCI, V16, P7880
  • [8] BUISSON B, 1997, IN PRESS GENETICS FO
  • [9] PRIMARY STRUCTURE AND EXPRESSION OF BETA-2 - A NOVEL SUBUNIT OF NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS
    DENERIS, ES
    CONNOLLY, J
    BOULTER, J
    WADA, E
    WADA, K
    SWANSON, LW
    PATRICK, J
    HEINEMANN, S
    [J]. NEURON, 1988, 1 (01) : 45 - 54
  • [10] STABLE EXPRESSION AND PHARMACOLOGICAL PROPERTIES OF THE HUMAN ALPHA(7) NICOTINIC ACETYLCHOLINE-RECEPTOR
    GOPALAKRISHNAN, M
    BUISSON, B
    TOUMA, E
    GIORDANO, T
    CAMPBELL, JE
    HU, IC
    DONNELYROBERTS, D
    ARNERIC, SP
    BERTRAND, D
    SULLIVAN, JP
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 290 (03): : 237 - 246